Completed

NCT Number: NCT00913172

Cost and Cost-effectiveness of PTB+ Treatment in Southern Ethiopia

Evidences for policy making and decision related to the cost of delivering tuberculosis (TB) control is lacking in Ethiopia. The investigators aimed to determine the cost and cost-effectiveness of involving health extension workers (HEWs) in TB treatment under the community-based initiative in Ethiopia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Smear-positive TB Cases

Sex eligibility

All sexes

Study type

Observational

Primary location

YAHC

Irgalem, Snnpr, 72, Ethiopia

About this study

Two treatment options were compared - health facility and community DOT. In 1995, Ethiopia adopted World Health Organization (WHO) recommended DOTS strategy for TB control. The treatment regimen for new smear-positive patients includes two months of ethambutol, rifampicin, isoniazid and pyrazinamide followed by six months of ethambutol and isoniazid. For children the continuation phase treatment was replaced by four months of rifampicin and isoniazid. Follow up sputum examinations were conducted at the end of 2, 5 and 7 months treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Pulmonary tuberculosis suspects of any age and sex

Exclusion criteria

Healthy individuals or non tuberculosis patients

Treatment and study plan

Treatment

Other

Directly observed treatment (DOT) by health extension workers (HEWs)

Other names: community based TB care

Primary outcomes

cost per successfully treated smear-positive case

Time frame: September 2006 to April 2008

Sponsors and collaborators

Lead sponsor

University of Bergen

Other

Registry information

Official study title

Improving Community Based TB Care in Southern Ethiopia Cost and Cost Effectiveness

Important dates

Study start: 2006
Primary completion: 2007
Study completion: 2008
First posted: Jun 4, 2009
Registry last updated: May 17, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.